CALZETTA, Luigino
 Distribuzione geografica
Continente #
NA - Nord America 3.613
EU - Europa 2.125
AS - Asia 316
SA - Sud America 8
OC - Oceania 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.072
Nazione #
US - Stati Uniti d'America 3.599
IE - Irlanda 1.083
SE - Svezia 473
IT - Italia 188
CN - Cina 172
FI - Finlandia 107
DE - Germania 75
SG - Singapore 69
AT - Austria 65
EE - Estonia 38
IN - India 35
GB - Regno Unito 26
BE - Belgio 19
CA - Canada 11
TR - Turchia 11
NL - Olanda 10
ID - Indonesia 9
ES - Italia 6
IR - Iran 6
RU - Federazione Russa 6
AR - Argentina 4
CH - Svizzera 4
FR - Francia 4
HR - Croazia 4
NZ - Nuova Zelanda 4
UA - Ucraina 4
HK - Hong Kong 3
HU - Ungheria 3
TW - Taiwan 3
ZA - Sudafrica 3
BG - Bulgaria 2
BR - Brasile 2
JP - Giappone 2
MX - Messico 2
PT - Portogallo 2
RO - Romania 2
VN - Vietnam 2
AL - Albania 1
AU - Australia 1
CL - Cile 1
CO - Colombia 1
EU - Europa 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MM - Myanmar 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 6.072
Città #
Chandler 1.266
Dublin 1.073
Ashburn 342
Princeton 256
Des Moines 144
Helsinki 106
Wilmington 89
Beijing 70
Vienna 65
Ann Arbor 59
Shanghai 42
Tallinn 38
Rome 28
Parma 26
Milan 24
Boardman 22
Bremen 19
Brussels 19
Fremont 19
Seattle 19
Redmond 18
New York 17
Los Angeles 15
Norwalk 15
Pune 13
Rockville 13
Bologna 12
Saint Louis 10
Chicago 9
Nanchang 9
Naples 9
Borås 8
Edinburgh 8
Falls Church 8
Guangzhou 8
Houston 8
Kocaeli 8
Grafing 7
Kolkata 7
Yogyakarta 7
Phoenix 6
Trecasali 6
London 4
Solbiate Olona 4
Toronto 4
Vaddangi 4
Visakhapatnam 4
Zagreb 4
Barcelona 3
Budapest 3
Cape Town 3
Central 3
Izmir 3
Jinan 3
Miami 3
Montechiarugolo 3
Nocera Inferiore 3
Pozzuoli 3
Quartu Sant'Elena 3
Radeberg 3
Singapore 3
St Petersburg 3
Taipei 3
Turin 3
Washington 3
Zurich 3
Andover 2
Belsize Park 2
Bengaluru 2
Boston 2
Cassino 2
Chekhov 2
Cipolletti 2
Columbus 2
Correggio 2
Council Bluffs 2
Cremona 2
Cumignano sul Naviglio 2
Huizen 2
Lecce 2
Macerata 2
Macerata Campania 2
Maryville 2
Montichiari 2
Monza 2
Nanjing 2
New Orleans 2
Plymouth Meeting 2
Redwood City 2
Reggio Calabria 2
Richmond Hill 2
Salerno 2
San Mateo 2
Serino 2
Sofia 2
South San Francisco 2
St Louis 2
Stockholm 2
Tabriz 2
Taizhou 2
Totale 4.093
Nome #
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 90
Small airways in asthma: from bench-to-bedside 82
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD 79
The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients 79
Coronavirus Disease 2019: COSeSco - A Risk Assessment Score to Predict the Risk of Pulmonary Sequelae in COVID-19 Patients 65
Dexamethasone in patients hospitalized with COVID-19: Whether, when and to whom 60
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 54
The impact of monoclonal antibodies on airway smooth muscle contractility in asthma: A systematic review 52
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 51
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study 50
A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD 50
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab 47
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review 45
Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system 45
Analysis of exhaled breath fingerprints and volatile organic compounds in COPD 45
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine 44
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 43
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines 42
A 6MWT index to predict O-2 flow correcting exercise induced SpO(2) desaturation in ILD 41
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review 41
Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume 41
Can placebo challenge test (Inducing a “nocebo effect”) be a suitable model to assess stress-induced bronchial obstruction? suggestions from the multidisciplinary working groups “stress-asthma” and “AAIITO regione campania” 41
Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms 40
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 40
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-Covid Patients with Normal Spirometry and Unexplained Dyspnoea 39
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 39
Oral corticosteroids dependence and biologic drugs in severe asthma: Myths or facts? a systematic review of real‐world evidence 39
SMART for the treatment of asthma: A network meta-analysis of real-world evidence 39
ANTI-INFLAMMATORY PROFILE OF N-ACETYLCYSTEINE IN HUMAN BRONCHI STIMULATED WITH LIPOPOLYSACCHARIDE 38
Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life? 38
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies 38
Cardiovascular disease in copd 38
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 37
Advances with glucocorticoids in the treatment of asthma: state of the art 37
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 36
A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD 36
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study 36
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs 36
The impact of comorbidities on severe asthma 36
Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A(2)alpha for the Treatment of Asthma 35
Onset of action of budesonide/formoterol Spiromax (R) compared with budesonide/formoterol Turbuhaler (R) in patients with COPD 35
Allergy in adolescent population (14-18 years) living in Campania region (southern Italy). A multicenter study 35
Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma 35
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference 35
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 34
Long-acting bronchodilators and synergistic interaction: a challenge across the currently available LABA/LAMA combinations 34
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate plus vilanterol for the treatment of asthma 34
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination 34
Detection of Small Airway Dysfunction in Asthmatic Patients by Spirometry and Impulse Oscillometry System 33
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? 33
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed 33
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients 33
The possible concomitant use of aeroallergen and food panels for skin prick testing might enhance the risk of generalized allergic reactions in children 33
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients 33
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 32
Optimizing drug delivery in COPD: The role of inhaler devices 32
Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile 32
Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs 32
Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations 32
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union 32
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 31
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 31
ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 31
Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD 31
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 31
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 31
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 31
The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle 30
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity 30
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment 30
LAMA/LABA Fixed Combinations for COPD Management: A Systematic Comparative Review 30
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways 30
Factors influencing the efficacy of COVID-19 vaccines: A quantitative synthesis of phase III trials 30
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease 29
Ensifentrine (RPL554): an inhaled "bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease 29
Unmet needs and relationship between general practitioners (GPS) and allergists living in Campania region (Southern Italy) 29
A pilot survey on the quality of life in respiratory rehabilitation carried out in COPD patients with severe respiratory failure: preliminary data of a novel Inpatient Respiratory Rehabilitation Questionnaire (IRRQ) 28
Emerging drugs for chronic obstructive pulmonary disease 28
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses 28
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review 28
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease 28
Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells 27
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens 27
Chronic cat allergen exposure and low sensitization: Possible limitations in patient selection? 27
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 27
Pharmacogenetic and pharmacogenomic considerations of asthma treatment 26
Pharmacology and Therapeutics of Bronchodilators 26
Diabetes mellitus among outpatients with COPD attending a university hospital 26
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 26
Step-up and step-down approaches in the treatment of asthma 26
Anxiety and depression in adolescents with asthma and in their parents. Is an increased basal cholinergic tone a possible further reason to explain the negative impact on asthma control? 26
Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link? 26
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 25
Is ICS-LAMA an alternative option to treat patients with COPD? 25
A Novel and Effective Balanced Intravenous-Inhalant Anaesthetic Protocol in Swine by Using Unrestricted Drugs 25
Partial nephrectomy using radiofrequency incremental bipolar generator with multi electrode probe: experimental study in bench pig kidneys 25
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 25
Oxidation pathway and exacerbations in COPD: the role of NAC 25
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis (vol 12, pg 3469, 2017) 25
Comparative studies of dual bronchodilation in COPD 25
Totale 3.644
Categoria #
all - tutte 34.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 4 0
2019/2020200 2 0 0 0 0 0 0 0 1 7 1 189
2020/202194 0 0 0 7 3 3 0 19 32 20 5 5
2021/20221.118 1 10 2 20 76 39 257 75 46 3 37 552
2022/20233.942 509 313 229 258 277 455 49 276 1.378 28 134 36
2023/20241.129 100 161 56 65 141 259 103 82 63 99 0 0
Totale 6.488